ChAdOx1
July 21, 2020
Subject: Science and tech Context: According to Lancet journal, avaccine AZD1222 developed at the University of Oxford has shown encouraging results in early human testing and appears to be “safe well-tolerated, and immunogenic”. Concept: The AZD1222 vaccine is based on a chimpanzee adenovirus called ChAdOx1 which elicited antibody and T-cell immune responses in human body. […]